Personal Drug Importation Fairness Act of 2015
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Personal Drug Importation Fairness Act of 2015
This bill allows a drug to be imported by a person other than the drug's manufacturer if the drug: (1) has the same active ingredients, route of administration, and strength as an approved drug; (2) may be lawfully marketed in, and is imported or reimported from, a country included on a list in this Act that the Food and Drug Administration determines has standards for ensuring drug safety and effectiveness that are at least as protective as U.S. standards; (3) is dispensed by a licensed pharmacist; (4) is shipped directly to, or is imported by, the ultimate consumer; (5) is shipped or imported in quantities that do not exceed a 90-day supply; (6) is accompanied by a copy of a valid prescription; and (7) is not a controlled substance.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 2623: Personal Drug Importation Fairness Act of 2015. 114th Congress. Open America. https://openamerica.io/bill/114-HR-2623/
"H.R. 2623: Personal Drug Importation Fairness Act of 2015." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-2623/.
H.R. 2623, 114th Cong. (2026), https://openamerica.io/bill/114-HR-2623/.
[H.R. 2623: Personal Drug Importation Fairness Act of 2015](https://openamerica.io/bill/114-HR-2623/)